Feedback / Questions
CYT-108 - Cytonics Corp
https://www.prnewswire.com/news-releases/cytonics-announces-that-last-patient-completes-last-visit-in-first-in-human-phase-1-clinical-trial-for-cyt-108-as-a-treatment-for-osteoarthritis-302415007.html
Apr 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next